CARB-X, the world’s largest PPP organisation combating Antimicrobial Resistance (AMR) globally is launching four new funding rounds to support the development of antibiotics, vaccines, diagnostics and other life-saving products targeting drug-resistant bacteria. Applications are invited from product developers around the world.
The funding call is divided into four rounds as below -
1) Round 1 - Non-traditional Approaches - June 3 - June10, 5pm ET
2) Round 2 - Vaccines & Biotherapeutics- July 8-July 15, 5pm ET
3) Round 3 - Diagnostics - August 12 - August 19, 5pm ET
4) Round 4 - Direct-acting small molecule antibiotics - November 12 - November 19, 5pm ET
See http://carb-x.org/2019funding/ for more details.
For any questions, reach out to for more info. Write to us at amr@ccamp.res.in
C-CAMP is part of the CARB-X Global Accelerator Network, GAN. It is the only CARB-X accelerator outside of USA and Europe and also the only dedicated AMR accelerator in India.
